Imlunestrant

Chemical formula: C₂₉H₂₄F₄N₂O₃  Molecular mass: 524.172 g/mol  PubChem compound: 146603228

Active ingredient description

Imlunestrant is an antagonist and degrader of wild-type and mutant oestrogen receptor-α (ERα), leading to inhibition of oestrogen receptor-dependent gene transcription and cellular proliferation in ER-positive breast cancer cells.

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Document Type Information Source  
 INLURIYO Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)
 INLURIYO Film-coated tablet MPI, US: SPL/PLR

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

DrugBank Drug: DB19043
KEGG Drug: D12216
PubChem Compound: 146603228
UNII Identifier: 9CXQ3PF69U
IMLUNESTRANT

Medicines

Imlunestrant is an active ingredient of these brands:

Austria (AT)

Lithuania (LT)

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈